Versions of 21 CFR Part 212 - Current Good Manufacturing Practice for Positron Emission Tomography Drugs on LawServer
2024 21 CFR Part 212 – Current Good Manufacturing Practice for Positron Emission Tomography Drugs
2023 21 CFR PART 212 – CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
2022 21 CFR Part 212 – Current Good Manufacturing Practice for Positron Emission Tomography Drugs
2021 21 CFR Part 212 – Current Good Manufacturing Practice for Positron Emission Tomography Drugs
2020 21 CFR Part 212 – Current Good Manufacturing Practice for Positron Emission Tomography Drugs